Literature DB >> 10913024

Malonyl-CoA content and fatty acid oxidation in rat muscle and liver in vivo.

D Chien1, D Dean, A K Saha, J P Flatt, N B Ruderman.   

Abstract

Malonyl-CoA acutely regulates fatty acid oxidation in liver in vivo by inhibiting carnitine palmitoyltransferase. Thus rapid increases in the concentration of malonyl-CoA, accompanied by decreases in long-chain fatty acyl carnitine (LCFA-carnitine) and fatty acid oxidation have been observed in liver of fasted-refed rats. It is less clear that it plays a similar role in skeletal muscle. To examine this question, whole body respiratory quotients (RQ) and the concentrations of malonyl-CoA and LCFA-carnitine in muscle were determined in 48-h-starved rats before and at various times after refeeding. RQ values were 0.82 at baseline and increased to 0.93, 1. 0, 1.05, and 1.09 after 1, 3, 12, and 18 h of refeeding, respectively, suggesting inhibition of fat oxidation in all tissues. The increases in RQ at each time point correlated closely (r = 0.98) with increases (50-250%) in the concentration of malonyl-CoA in soleus and gastrocnemius muscles and decreases in plasma FFA and muscle LCFA-carnitine levels. Similar changes in malonyl-CoA and LCFA-carnitine were observed in liver. The increases in malonyl-CoA in muscle during refeeding were not associated with increases in the assayable activity of acetyl-CoA carboxylase (ACC) or decreases in the activity of malonyl-CoA decarboxylase (MCD). The results suggest that, during refeeding after a fast, decreases in fatty acid oxidation occur rapidly in muscle and are attributable both to decreases in plasma FFA and increases in the concentration of malonyl-CoA. They also suggest that the increase in malonyl-CoA in this situation is not due to changes in the assayable activity of either ACC or MCD or an increase in the cytosolic concentration of citrate.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10913024     DOI: 10.1152/ajpendo.2000.279.2.E259

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  23 in total

1.  Malonyl coenzyme A and the regulation of functional carnitine palmitoyltransferase-1 activity and fat oxidation in human skeletal muscle.

Authors:  Blake B Rasmussen; Ulf C Holmbäck; Elena Volpi; Beatrice Morio-Liondore; Douglas Paddon-Jones; Robert R Wolfe
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

Review 2.  Regulation and limitations to fatty acid oxidation during exercise.

Authors:  Jacob Jeppesen; Bente Kiens
Journal:  J Physiol       Date:  2012-01-23       Impact factor: 5.182

3.  Disruption of adenosine 2A receptor exacerbates NAFLD through increasing inflammatory responses and SREBP1c activity.

Authors:  Yuli Cai; Honggui Li; Mengyang Liu; Ya Pei; Juan Zheng; Jing Zhou; Xianjun Luo; Wenya Huang; Linqiang Ma; Qiuhua Yang; Shaodong Guo; Xiaoqiu Xiao; Qifu Li; Tianshu Zeng; Fanyin Meng; Heather Francis; Shannon Glaser; Lulu Chen; Yuqing Huo; Gianfranco Alpini; Chaodong Wu
Journal:  Hepatology       Date:  2018-05-10       Impact factor: 17.425

4.  Measurement of precursor enrichment for calculating intramuscular triglyceride fractional synthetic rate.

Authors:  Xiao-Jun Zhang; Noe A Rodriguez; Lijian Wang; Demidmaa Tuvdendorj; Zhanpin Wu; Alai Tan; David N Herndon; Robert R Wolfe
Journal:  J Lipid Res       Date:  2011-09-20       Impact factor: 5.922

Review 5.  Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects.

Authors:  Stephanie E Reuter; Allan M Evans
Journal:  Clin Pharmacokinet       Date:  2012-09-01       Impact factor: 6.447

6.  Peroxisome proliferator-activated receptors as targets to treat non-alcoholic fatty liver disease.

Authors:  Vanessa Souza-Mello
Journal:  World J Hepatol       Date:  2015-05-18

7.  Phosphorylation of Acetyl-CoA Carboxylase by AMPK Reduces Renal Fibrosis and Is Essential for the Anti-Fibrotic Effect of Metformin.

Authors:  Mardiana Lee; Marina Katerelos; Kurt Gleich; Sandra Galic; Bruce E Kemp; Peter F Mount; David A Power
Journal:  J Am Soc Nephrol       Date:  2018-07-05       Impact factor: 10.121

8.  Identification of a novel malonyl-CoA IC(50) for CPT-I: implications for predicting in vivo fatty acid oxidation rates.

Authors:  Brennan K Smith; Christopher G R Perry; Timothy R Koves; David C Wright; Jeffrey C Smith; P Darrell Neufer; Deborah M Muoio; Graham P Holloway
Journal:  Biochem J       Date:  2012-11-15       Impact factor: 3.857

9.  Ribosomal protein-Mdm2-p53 pathway coordinates nutrient stress with lipid metabolism by regulating MCD and promoting fatty acid oxidation.

Authors:  Yong Liu; Yizhou He; Aiwen Jin; Andrey P Tikunov; Lishi Zhou; Laura A Tollini; Patrick Leslie; Tae-Hyung Kim; Lei O Li; Rosalind A Coleman; Zhennan Gu; Yong Q Chen; Jeffrey M Macdonald; Lee M Graves; Yanping Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-28       Impact factor: 11.205

10.  Novel role of FATP1 in mitochondrial fatty acid oxidation in skeletal muscle cells.

Authors:  David Sebastián; Maria Guitart; Celia García-Martínez; Caroline Mauvezin; Josep M Orellana-Gavaldà; Dolors Serra; Anna M Gómez-Foix; Fausto G Hegardt; Guillermina Asins
Journal:  J Lipid Res       Date:  2009-05-09       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.